SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 132.39-0.7%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (931)5/14/2002 12:00:02 AM
From: Miljenko Zuanic  Read Replies (1) of 1834
 
Early concern about 34060 patent protection expiration in "03 is evaporating.

United States Patent 6,384,221
Thiele , et al. May 7, 2002

--------------------------------------------------------------------------------
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl} phenyl)acetamide and compositions and methods related thereto

Abstract
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl} phenyl)acetamide (Compound 1), and use of the same as a sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent. Processes for making the same, as well as related compositions and methods are also disclosed, particularly with regard to treatment of insomnia. A polymorph Form I possessing exception physical and heat stability is provided. A polymorph Form II ##STR1##

--------------------------------------------------------------------------------
Inventors: Thiele; William Jay (San Diego, CA); O'Donnell; Patrick B. (San Diego, CA)
Assignee: Neurocrine Biosciences, Inc. (San Diego, CA)
Appl. No.: 654447
Filed: September 1, 2000
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext